Anti-Nuclear Receptor LXR alpha, beta (NR1H3, LXRA, LXR-a, RLD-1, nuclear receptor subfamily 1, grou

Alternate Name: NR1H3, LXRA, LXR-a, RLD-1, nuclear receptor subfamily 1, group H, member 3, liver X receptor, alpha, NR1H2, NER, UNR, LXR-b, NER-I, RIP15, nuclear receptor subfamily 1, group H, member 2, ubiquitously-expressed nuclear receptor / NR1H2, NER, UNR, LXR-b, NER-I, RIP15, nuclear receptor subfamily 1, group H, member 2, ubiquitously-expressed nuclear receptor, Domain Information: , Gene Ontology Terms: nucleus, regulation of transcription, DNA-dependent, steroid hormone receptor activity, thyroid hormone receptor activity, transcription coactivator activity, transcription factor activity, Application(s): Peptide ELISA: antibody detection limit dilution 1:32,000. Western Blot: Approx 55kD band observed in Human Spleen lysates (calculated MW of 50.5kD according to NP_005684 and 50.1kD according to NP_009052). Recommended concentration: 1-3ug/ml. Additional minor bands were also consistently observed at 38kD and 75kD. These bands were successfully blocked by incubation with the immunizing peptide. 1ug/ml staining of Human Spleen lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. For long-term storage and to avoid repeated freezing and thawing, aliquot and store at -20°C. Aliquots are stable for at least 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. Peptide Blocking: Corresponding peptide is available for Peptide Blocking studies. See N6889-83-P. Antibody is typically 0.5mg/ml and peptide is supplied as a 100ul pellet. When peptide is reconstituted in 200ul water, the concentration would also be 0.5mg/ml. To start, the best ratio would be 1:1 (molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volumes of peptide and antibody at the required dilution and leave at ambient temperature. It is best is to have two identical blots to be incubated with equal amount of antibody, but one with the antibody pre-adsorbed to the peptide for 20min. Then incubate and develop the two blots in parallel.